About
About China Biotech Services Holdings Limited
China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron neutron capture therapy treatment services, as well as provision of logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.
Visit company website
5 years, 5 months ago
China Biotech Services Holdings Limited is currently in a long term uptrend where the price is trading 26.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
China Biotech Services Holdings Limited's total revenue rose by 559.4% to $109M since the same quarter in the previous year.
Its net income has increased by 120.2% to $9M since the same quarter in the previous year.
Finally, its free cash flow grew by 1492.5% to $422M since the same quarter in the previous year.
Based on the above factors, China Biotech Services Holdings Limited gets an overall score of 5/5.